{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04976634",
            "orgStudyIdInfo": {
                "id": "6482-016"
            },
            "secondaryIdInfos": [
                {
                    "id": "MK-6482-016",
                    "type": "OTHER",
                    "domain": "Merck"
                },
                {
                    "id": "2020-005007-40",
                    "type": "EUDRACT_NUMBER"
                }
            ],
            "organization": {
                "fullName": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            },
            "briefTitle": "Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Solid Tumors (MK-6482-016)",
            "officialTitle": "An Open-label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab Plus Lenvatinib in Combination With Belzutifan in Multiple Solid Tumors",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "pembrolizumab-plus-lenvatinib-in-combination-with-belzutifan-in-solid-tumors-mk"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-08-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-03-22",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-03-22",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-07-16",
            "studyFirstSubmitQcDate": "2021-07-16",
            "studyFirstPostDateStruct": {
                "date": "2021-07-26",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-26",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-30",
                "type": "ESTIMATED"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Merck Sharp & Dohme LLC",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to determine the safety and efficacy of belzutifan in combination with pembrolizumab and lenvatinib in multiple solid tumors including hepatocellular carcinoma (HCC), colorectal cancer (CRC), pancreatic ductal adenocarcinoma (PDAC), biliary tract cancer (BTC), endometrial cancer (EC),and esophageal squamous cell carcinoma (ESCC). There is no formal hypothesis testing in this study."
        },
        "conditionsModule": {
            "conditions": [
                "Carcinoma, Hepatocellular",
                "Colorectal Neoplasms",
                "Pancreatic Ductal Adenocarcinoma",
                "Biliary Tract Neoplasms",
                "Endometrial Neoplasms",
                "Esophageal Neoplasms"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 730,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Arm 1: Pembrolizumab + Belzutifan + Lenvatinib",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive pembrolizumab 400 mg PLUS belzutifan 120 mg PLUS lenvatinib 20 mg (For HCC: 8 mg \\[body weight \\<60kg\\] or 12 mg \\[body weight \u2265 60 kg\\]). Pembrolizumab will be administered via intravenous (IV) infusion once every 6 weeks (Q6W) for a maximum of 18 doses (approximately 2 years). Belzutifan and lenvatinib will be administered orally once daily (QD) until progressive disease or discontinuation.",
                    "interventionNames": [
                        "Drug: Pembrolizumab",
                        "Drug: Belzutifan",
                        "Drug: Lenvatinib"
                    ]
                },
                {
                    "label": "Arm 2: Pembrolizumab + Lenvatinib",
                    "type": "EXPERIMENTAL",
                    "description": "Participants with IO resistant ESCC will receive pembrolizumab 400 mg PLUS lenvatinib 20 mg. Pembrolizumab will be administered via intravenous (IV) infusion once every 6 weeks (Q6W) for a maximum of 18 doses (approximately 2 years). Lenvatinib will be administered orally once daily (QD) until progressive disease or discontinuation.",
                    "interventionNames": [
                        "Drug: Pembrolizumab",
                        "Drug: Lenvatinib"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Pembrolizumab",
                    "description": "Pembrolizumab 400 mg administered Q6W via IV infusion",
                    "armGroupLabels": [
                        "Arm 1: Pembrolizumab + Belzutifan + Lenvatinib",
                        "Arm 2: Pembrolizumab + Lenvatinib"
                    ],
                    "otherNames": [
                        "MK-3475",
                        "KEYTRUDA\u00ae"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Belzutifan",
                    "description": "Belzutifan 120 mg administered QD via oral tablet",
                    "armGroupLabels": [
                        "Arm 1: Pembrolizumab + Belzutifan + Lenvatinib"
                    ],
                    "otherNames": [
                        "MK-6482",
                        "PT2977",
                        "WELIREG\u2122"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Lenvatinib",
                    "description": "Lenvantinib dose for HCC is 8 mg QD for body weight \\<60 kg and 12 mg QD for body weight \u2265 60 kg administered via oral capsule. For all other tumors, the lenvatinib dose is 20 mg QD administered via oral capsule",
                    "armGroupLabels": [
                        "Arm 1: Pembrolizumab + Belzutifan + Lenvatinib",
                        "Arm 2: Pembrolizumab + Lenvatinib"
                    ],
                    "otherNames": [
                        "MK-7902",
                        "E7080",
                        "LENVIMA\u00ae"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Arm 1: Number of Participants Who Experience at Least One Dose-limiting Toxicity (DLT)",
                    "description": "Occurrence of any of the following will be considered a DLT if possibly, probably, or definitely related to study treatment administration: Grade 4 nonhematologic toxicity; Grade 4 hematologic toxicity lasting \\>7 days; Grade 4 thrombocytopenia-any duration; Grade 3 thrombocytopenia if associated with clinically significant hemorrhage; Febrile neutropenia Grade 3 or Grade 4; Grade 3 nonhematologic toxicity lasting \\>5 days despite optimal supportive care; Grade 3 hypertension not controlled by antihypertensive medication(s); Grade 3 or Grade 4 nonhematologic laboratory abnormality (if medical intervention is required, or leads to hospitalization, or persists for \\>1 week) ; Elevated bilirubin if persists \\>4 weeks (for HCC and BTC participants only); Designated alanine aminotransferase (ALT) or aspartate aminotransferase (AST) liver test abnormalities; Treatment-related toxicity resulting in participant discontinuation of study intervention during the DLT window; Grade 5 toxicity.",
                    "timeFrame": "Up to approximately 21 days"
                },
                {
                    "measure": "Arm 1: Number of Participants Who Experience at Least One Adverse Event (AE)",
                    "description": "An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants who experience one or more AEs will be presented.",
                    "timeFrame": "Up to approximately 60 months"
                },
                {
                    "measure": "Arm 1: Number of Participants Who Discontinue Study Treatment Due to an AE",
                    "description": "An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants who discontinue study treatment due to an AE will be presented separately for the safety lead-in phase (up to 21 days) and the main study.",
                    "timeFrame": "Up to approximately 59 months"
                },
                {
                    "measure": "Confirmed Objective Response Rate (ORR) Per Response Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as Assessed by Blinded Independent Central Review (BICR)",
                    "description": "ORR is defined as the percentage of participants who have a Complete Response (CR) or a Partial Response (PR) per RECIST 1.1, as assessed by blinded independent central review (BICR).",
                    "timeFrame": "Up to approximately 60 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Duration of Response (DOR) Per RECIST 1.1 as Assessed by BICR",
                    "description": "DOR is defined as the time from first documented evidence of CR or PR until progressive disease (PD) or death due to any cause, whichever occurs first. The DOR per RECIST 1.1 will be assessed by BICR.",
                    "timeFrame": "Up to approximately 60 months"
                },
                {
                    "measure": "Disease Control Rate (DCR) Per RECIST 1.1 as Assessed by BICR",
                    "description": "DCR is defined as the percentage of participants who have a CR, PR, or Stable Disease (SD). The best overall response of CR, PR, or SD after \u2265 6 weeks will be assessed per RECIST 1.1 by BICR.",
                    "timeFrame": "Up to approximately 60 months"
                },
                {
                    "measure": "Progression-Free Survival (PFS) Per RECIST 1.1 as Assessed by BICR",
                    "description": "PFS is defined as the time from first day of study intervention to the first documented progressive disease (PD) per RECIST1.1 as assessed by BICR, or death due to any cause, whichever occurs first.",
                    "timeFrame": "Up to approximately 60 months"
                },
                {
                    "measure": "Overall Survival (OS)",
                    "description": "OS is defined as the time from the first day of study intervention to death due to any cause.",
                    "timeFrame": "Up to approximately 60 months"
                },
                {
                    "measure": "ORR Per Modified Response Criteria in Solid Tumors Version 1.1 (mRECIST 1.1) for Hepatocellular Carcinoma (HCC) as Assessed by BICR",
                    "description": "ORR is defined as the percentage of participants who have a CR or a PR per mRECIST 1.1 for HCC, as assessed by BICR.",
                    "timeFrame": "Up to approximately 60 months"
                },
                {
                    "measure": "DOR Per mRECIST 1.1 for HCC as Assessed by BICR",
                    "description": "DOR is defined as the time from the first documented evidence of CR or PR until either progressive disease (PD) or death due to any cause, whichever occurs first. The DOR per mRECISIT 1.1 for HCC willl be assessed by BICR.",
                    "timeFrame": "Up to approximately 60 months"
                },
                {
                    "measure": "DCR Per mRECIST 1.1 for HCC as Assessed by BICR",
                    "description": "DCR is defined as the percentage of participants who have a CR or PR or SD. The best overall response of CR, PR, or SD after \u2265 6 weeks per mRECIST 1.1 for HCC will be assessed by BICR.",
                    "timeFrame": "Up to approximately 60 months"
                },
                {
                    "measure": "PFS Per mRECIST 1.1 for HCC as Assessed by BICR",
                    "description": "PFS is defined as the time from first day of study intervention to the first documented PD per mRECIST 1.1 for HCC as assessed by BICR, or death due to any cause, whichever occurs first.",
                    "timeFrame": "Up to approximately 60 months"
                },
                {
                    "measure": "Arm 2: Number of Participants Who Experienced an Adverse Event (AE)",
                    "description": "An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants who experience an AE after administration of pembrolizumab plus lenvatinib will be presented.",
                    "timeFrame": "Up to approximately 60 months"
                },
                {
                    "measure": "Arm 2: Number of Participants Who Discontinued Study Treatment Due to an AE",
                    "description": "An AE is defined as any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. The number of participants who discontinue study treatment of pembrolizumab plus lenvatinib after an AE will be presented.",
                    "timeFrame": "Up to approximately 59 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosis of one of the following advanced (unresectable and/or metastatic) solid tumors, documented by histopathology or cytopathology:\n\n  * Hepatocellular carcinoma (HCC)\n  * Colorectal cancer (CRC) (non-microsatellite instability-high \\[non-MSI-H\\]/deficient mismatch repair \\[dMMR\\])\n  * Pancreatic ductal adenocarcinoma (PDAC).\n  * Biliary tract cancer (BTC) (includes intrahepatic, extrahepatic cholangiocarcinoma \\[CCA\\] and gall bladder cancer)\n  * Endometrial cancer (EC)\n  * Esophageal squamous cell carcinoma (ESCC)\n* Disease progression on or since the most recent treatment (does not apply to newly diagnosed unresectable or metastatic HCC or EC).\n* Measurable disease per RECIST v1.1 as assessed locally (by investigator) and verified by BICR\n* Submission of an archival tumor tissue sample or newly obtained core or excisional biopsy of a tumor lesion not previously irradiated\n* Male participants are abstinent from heterosexual intercourse or agree to follow contraceptive guidance during and for at least 7 days after last dose of study intervention with belzutifan and lenvatinib\n* Female participants are not pregnant or breastfeeding, not a woman of child-bearing potential (WOCBP), or is a WOCBP and agrees to follow contraceptive guidance during the intervention period and and for at least 120 days after the last dose of pembrolizumab or for at least 30 days after last dose of lenvatinib or belzutifan, whichever occurs last\n* Adequate organ function\n* Adequately controlled blood pressure with or without antihypertensive medications\n* HCC Specific Inclusion Criteria: No prior systemic chemotherapy, including anti-VEGF therapy, anti-programmed cell-death (PD-1)/PD-L1 or any systemic investigational anticancer agents for advanced/unresectable HCC (1L)\n* CRC (\\[non-MSI-H/dMMR) Specific Inclusion Criteria: Received at least 2 prior lines of systemic therapy for unresectable or metastatic disease which includes fluoropyrimidine, irinotecan and oxaliplatin\n* PDAC Specific Inclusion Criteria: Prior therapy with at least 1 (platinum or gemcitabine containing regimen) but no more than 2 prior systemic therapies for unresectable or metastatic pancreatic cancer\n* BTC Specific Inclusion Criteria: Received at least 1 prior line of systemic therapy (containing gemcitabine or fluoropyrimidine) for unresectable or metastatic disease\n* EC Specific Inclusion Criteria: Study treatment is for 1L therapy of EC and participants should not have received prior systemic chemotherapy. Exception: May have received 1 prior line of line of systemic platinum-based adjuvant and/or neoadjuvant chemotherapy in the setting of a curative-intent resection, if the recurrence occurred \u22656 months after the last dose of chemotherapy or may have received prior radiation with or without chemotherapy\n* ESCC Specific Inclusion Criteria: Have experienced radiographic or clinical progression on one prior line of standard systemic therapy (immune oncology (IO) na\u00efve participants) or an anti-PD-1/PD-L1 (IO resistant participants)\n\nExclusion Criteria:\n\n* Unable to swallow orally administered medication or presence of a gastrointestinal (GI) disorder that may affect study intervention absorption\n* History of a second malignancy that is progressing or has required active treatment within 3 years\n* A pulse oximeter reading \\<92% at rest, or requirement of intermittent supplemental oxygen/ chronic supplemental oxygen\n* Presence of central nervous system (CNS) metastases and/or carcinomatous meningitis\n* Clinically significant cardiovascular disease within 6 months of first dose of study intervention\n* Symptomatic pleural effusion, unless clinically stable after treatment\n* Preexisting \u2265 Grade 3 gastrointestinal (GI) or non-GI fistula\n* Moderate to severe hepatic impairment\n* Clinically significant history of bleeding within 3 months before screening\n* Presence of serious active nonhealing wound/ulcer/bone fracture\n* Requirement for hemodialysis or peritoneal dialysis\n* History of human immunodeficiency virus (HIV) infection\n* History of Hepatitis B or active Hepatis C virus infections. with exceptions for HCC and BTC\n* Prior therapy with a PD-1, anti-PD-L1, anti-PD-L2 agent, vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) or hypoxia-inducible factor 2\u03b1 (HIF-2\u03b1)\n* Radiographic evidence of intratumoral cavitation, or invasion/infiltration of a major blood vessel\n* EC specific exclusion criteria: History of carcinosarcoma, endometrial leiomyosarcoma or other high-grade sarcomas, or endometrial stromal sarcomas\n* ESCC specific exclusion criteria: Has clinically apparent ascites or pleural effusion or experienced weight loss \\>20% over approximately 3 months before first dose of study therapy",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Toll Free Number",
                    "role": "CONTACT",
                    "phone": "1-888-577-8839",
                    "email": "Trialsites@merck.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Medical Director",
                    "affiliation": "Merck Sharp & Dohme LLC",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Arizona Cancer Center-University of Arizona Cancer Center - North Campus ( Site 5047)",
                    "status": "COMPLETED",
                    "city": "Tucson",
                    "state": "Arizona",
                    "zip": "85724",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.22174,
                        "lon": -110.92648
                    }
                },
                {
                    "facility": "City of Hope Comprehensive Cancer Center ( Site 5002)",
                    "status": "COMPLETED",
                    "city": "Duarte",
                    "state": "California",
                    "zip": "91010",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.13945,
                        "lon": -117.97729
                    }
                },
                {
                    "facility": "Cedars-Sinai Medical Center ( Site 5045)",
                    "status": "RECRUITING",
                    "city": "Los Angeles",
                    "state": "California",
                    "zip": "90048",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "310-423-5776"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.05223,
                        "lon": -118.24368
                    }
                },
                {
                    "facility": "UCSF Medical Center at Mission Bay ( Site 5021)",
                    "status": "RECRUITING",
                    "city": "San Francisco",
                    "state": "California",
                    "zip": "94158",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "415-353-9888"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.77493,
                        "lon": -122.41942
                    }
                },
                {
                    "facility": "Yale-New Haven Hospital-Yale Cancer Center ( Site 5013)",
                    "status": "COMPLETED",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06510",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                },
                {
                    "facility": "Sibley Memorial Hospital ( Site 5051)",
                    "status": "RECRUITING",
                    "city": "Washington",
                    "state": "District of Columbia",
                    "zip": "20016",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "410-955-6832"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.89511,
                        "lon": -77.03637
                    }
                },
                {
                    "facility": "University of Florida College of Medicine ( Site 5015)",
                    "status": "RECRUITING",
                    "city": "Gainesville",
                    "state": "Florida",
                    "zip": "32610",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "352-273-7990"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.65163,
                        "lon": -82.32483
                    }
                },
                {
                    "facility": "Johns Hopkins Hospital-Sidney Kimmel Comprehensive Cancer Center - GI and Immunology ( Site 5048)",
                    "status": "COMPLETED",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21287",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "Brigitte Harris Cancer Pavilion ( Site 5055)",
                    "status": "RECRUITING",
                    "city": "Detroit",
                    "state": "Michigan",
                    "zip": "48202",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "313-916-1841"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.33143,
                        "lon": -83.04575
                    }
                },
                {
                    "facility": "Memorial Sloan Kettering Cancer Center ( Site 5050)",
                    "status": "COMPLETED",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10065",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Duke Cancer Institute ( Site 5026)",
                    "status": "RECRUITING",
                    "city": "Durham",
                    "state": "North Carolina",
                    "zip": "27710",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "919-684-8111"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.99403,
                        "lon": -78.89862
                    }
                },
                {
                    "facility": "University of Texas MD Anderson Cancer Center-Gastrointestinal Medical Oncology ( Site 5049)",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "713-563-4799"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Inova Schar Cancer Institute ( Site 5039)",
                    "status": "RECRUITING",
                    "city": "Fairfax",
                    "state": "Virginia",
                    "zip": "22031",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "571-472-4724"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.84622,
                        "lon": -77.30637
                    }
                },
                {
                    "facility": "Blue Ridge Cancer Care ( Site 5053)",
                    "status": "RECRUITING",
                    "city": "Roanoke",
                    "state": "Virginia",
                    "zip": "24014",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "540-982-0237"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.27097,
                        "lon": -79.94143
                    }
                },
                {
                    "facility": "Northwest Medical Specialties, PLLC ( Site 5025)",
                    "status": "RECRUITING",
                    "city": "Tacoma",
                    "state": "Washington",
                    "zip": "98405",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "253-381-0674"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.25288,
                        "lon": -122.44429
                    }
                },
                {
                    "facility": "University of Wisconsin Hospitals and Clinics ( Site 5037)",
                    "status": "RECRUITING",
                    "city": "Madison",
                    "state": "Wisconsin",
                    "zip": "53792",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "608-265-9966"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.07305,
                        "lon": -89.40123
                    }
                },
                {
                    "facility": "Gosford Hospital-Oncology Trials ( Site 4004)",
                    "status": "COMPLETED",
                    "city": "Gosford",
                    "state": "New South Wales",
                    "zip": "2250",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -33.4244,
                        "lon": 151.34399
                    }
                },
                {
                    "facility": "Westmead Hospital-Department of Medical Oncology ( Site 4001)",
                    "status": "RECRUITING",
                    "city": "Westmead",
                    "state": "New South Wales",
                    "zip": "2145",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+61288908935"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.80383,
                        "lon": 150.98768
                    }
                },
                {
                    "facility": "Northern Hospital-Department of Medical Oncology ( Site 4003)",
                    "status": "RECRUITING",
                    "city": "Epping",
                    "state": "Victoria",
                    "zip": "3076",
                    "country": "Australia",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "6138405 8303"
                        }
                    ],
                    "geoPoint": {
                        "lat": -37.65,
                        "lon": 145.03333
                    }
                },
                {
                    "facility": "Cabrini Hospital - Malvern-Cabrini Institute ( Site 4000)",
                    "status": "COMPLETED",
                    "city": "Malvern",
                    "state": "Victoria",
                    "zip": "3144",
                    "country": "Australia",
                    "geoPoint": {
                        "lat": -32.02849,
                        "lon": 151.32225
                    }
                },
                {
                    "facility": "Antwerp University Hospital-Oncology ( Site 1002)",
                    "status": "RECRUITING",
                    "city": "Edegem",
                    "state": "Antwerpen",
                    "zip": "2650",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+32 3 821 55 80"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.15662,
                        "lon": 4.44504
                    }
                },
                {
                    "facility": "Cliniques universitaires Saint-Luc-Medical Oncology ( Site 1001)",
                    "status": "RECRUITING",
                    "city": "Brussels",
                    "state": "Bruxelles-Capitale, Region De",
                    "zip": "1200",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+3227641041"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.85045,
                        "lon": 4.34878
                    }
                },
                {
                    "facility": "Universit\u00e9 Catholique de Louvain-Namur - Centre Hospitalier -Oncology ( Site 1003)",
                    "status": "RECRUITING",
                    "city": "Yvoir",
                    "state": "Namur",
                    "zip": "5530",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "3281423849"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.3279,
                        "lon": 4.88059
                    }
                },
                {
                    "facility": "UZ Leuven ( Site 1000)",
                    "status": "RECRUITING",
                    "city": "Leuven",
                    "state": "Vlaams-Brabant",
                    "zip": "3000",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "3216344218"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.87959,
                        "lon": 4.70093
                    }
                },
                {
                    "facility": "AZ Delta vzw ( Site 1004)",
                    "status": "RECRUITING",
                    "city": "Roeselare",
                    "state": "West-Vlaanderen",
                    "zip": "8800",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+3251237215"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.94653,
                        "lon": 3.12269
                    }
                },
                {
                    "facility": "Centro Investigaci\u00f3n del C\u00e1ncer James Lind ( Site 3107)",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Temuco",
                    "state": "Araucania",
                    "zip": "4800827",
                    "country": "Chile",
                    "geoPoint": {
                        "lat": -38.73965,
                        "lon": -72.59842
                    }
                },
                {
                    "facility": "Cl\u00ednica Puerto Montt ( Site 3110)",
                    "status": "RECRUITING",
                    "city": "Puerto Montt",
                    "state": "Los Lagos",
                    "zip": "5500243",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+56998634501"
                        }
                    ],
                    "geoPoint": {
                        "lat": -41.46691,
                        "lon": -72.94956
                    }
                },
                {
                    "facility": "FALP-UIDO ( Site 3102)",
                    "status": "ACTIVE_NOT_RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "7500921",
                    "country": "Chile",
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Oncovida ( Site 3108)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "7510032",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+56323320850"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Bradfordhill-Clinical Area ( Site 3100)",
                    "status": "RECRUITING",
                    "city": "Santiago",
                    "state": "Region M. De Santiago",
                    "zip": "8420383",
                    "country": "Chile",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+56229490970"
                        }
                    ],
                    "geoPoint": {
                        "lat": -33.45694,
                        "lon": -70.64827
                    }
                },
                {
                    "facility": "Centre Eug\u00e8ne Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 1103)",
                    "status": "RECRUITING",
                    "city": "Rennes",
                    "state": "Bretagne",
                    "zip": "35042",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+33299253196"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.11198,
                        "lon": -1.67429
                    }
                },
                {
                    "facility": "CHU Besan\u00e7on-Medical oncology ( Site 1101)",
                    "status": "RECRUITING",
                    "city": "Besan\u00e7on",
                    "state": "Doubs",
                    "zip": "25000",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+33370632237"
                        }
                    ],
                    "geoPoint": {
                        "lat": 47.24878,
                        "lon": 6.01815
                    }
                },
                {
                    "facility": "CHU Brest Cavale Blanche ( Site 1107)",
                    "status": "RECRUITING",
                    "city": "Brest",
                    "state": "Finistere",
                    "zip": "29200",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "33298223428"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.3903,
                        "lon": -4.48628
                    }
                },
                {
                    "facility": "Institut Regional du Cancer Montpellier ( Site 1106)",
                    "status": "RECRUITING",
                    "city": "Montpellier",
                    "state": "Herault",
                    "zip": "34298",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "33467612304"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.61092,
                        "lon": 3.87723
                    }
                },
                {
                    "facility": "H\u00f4pital Beaujon-Oncologie Digestive ( Site 1104)",
                    "status": "RECRUITING",
                    "city": "Clichy",
                    "state": "Ile-de-France",
                    "zip": "92110",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+33140875614"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.90018,
                        "lon": 2.30952
                    }
                },
                {
                    "facility": "Centre Hospitalier Universitaire de Grenoble-Medical Oncology ( Site 1105)",
                    "status": "RECRUITING",
                    "city": "La Tronche",
                    "state": "Isere",
                    "zip": "38700",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "33476765450"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.20429,
                        "lon": 5.73645
                    }
                },
                {
                    "facility": "Sainte Catherine Institut du Cancer Avignon Provence ( Site 1108)",
                    "status": "RECRUITING",
                    "city": "Avignon",
                    "state": "Vaucluse",
                    "zip": "84000",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "33490276268"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.94834,
                        "lon": 4.80892
                    }
                },
                {
                    "facility": "Rambam Health Care Campus-Oncology ( Site 1300)",
                    "status": "RECRUITING",
                    "city": "Haifa",
                    "zip": "3109601",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+97247776700"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.81841,
                        "lon": 34.9885
                    }
                },
                {
                    "facility": "Hadassah Medical Center-Oncology ( Site 1303)",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "zip": "9112001",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "97226777957"
                        }
                    ],
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Sheba Medical Center-ONCOLOGY ( Site 1302)",
                    "status": "RECRUITING",
                    "city": "Ramat Gan",
                    "zip": "5265601",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "97235307776"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08227,
                        "lon": 34.81065
                    }
                },
                {
                    "facility": "Sourasky Medical Center-Oncology ( Site 1301)",
                    "status": "RECRUITING",
                    "city": "Tel Aviv",
                    "zip": "6423906",
                    "country": "Israel",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "97236973082"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "Chonnam National University Hwasun Hospital-Hemato-Oncology ( Site 4105)",
                    "status": "RECRUITING",
                    "city": "Hwasun Gun",
                    "state": "Jeonranamdo",
                    "zip": "58128",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82613797633"
                        }
                    ]
                },
                {
                    "facility": "Keimyung University Dongsan Hospital CRC room 1 ( Site 4104)",
                    "status": "RECRUITING",
                    "city": "Daegu",
                    "state": "Taegu-Kwangyokshi",
                    "zip": "42601",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82532586671"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.87028,
                        "lon": 128.59111
                    }
                },
                {
                    "facility": "Seoul National University Hospital-Internal Medicine ( Site 4103)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03080",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82220723943"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Severance Hospital, Yonsei University Health System-Medical oncology ( Site 4100)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "03722",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82222288050"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Asan Medical Center-Department of Oncology ( Site 4101)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "05505",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82230101720"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Samsung Medical Center-Division of Hematology/Oncology ( Site 4102)",
                    "status": "RECRUITING",
                    "city": "Seoul",
                    "zip": "06351",
                    "country": "Korea, Republic of",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "82234103459"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.566,
                        "lon": 126.9784
                    }
                },
                {
                    "facility": "Maastricht UMC+-Medical Oncology ( Site 1501)",
                    "status": "RECRUITING",
                    "city": "Maastricht",
                    "state": "Limburg",
                    "zip": "6229 HX",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+31433872001"
                        }
                    ],
                    "geoPoint": {
                        "lat": 50.84833,
                        "lon": 5.68889
                    }
                },
                {
                    "facility": "Leids Universitair Medisch Centrum-Medical Oncology ( Site 1504)",
                    "status": "RECRUITING",
                    "city": "Leiden",
                    "state": "Zuid-Holland",
                    "zip": "2333 ZA",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+31715298849"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.15833,
                        "lon": 4.49306
                    }
                },
                {
                    "facility": "Universitair Medisch Centrum Utrecht-Medical Oncology ( Site 1503)",
                    "status": "RECRUITING",
                    "city": "Utrecht",
                    "zip": "3584 CX",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+31887556308"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.09083,
                        "lon": 5.12222
                    }
                },
                {
                    "facility": "Auckland City Hospital-Liver Research Unit ( Site 4201)",
                    "status": "RECRUITING",
                    "city": "Grafton",
                    "state": "Auckland",
                    "zip": "1023",
                    "country": "New Zealand",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+6493074949"
                        }
                    ],
                    "geoPoint": {
                        "lat": -36.86029,
                        "lon": 174.76566
                    }
                },
                {
                    "facility": "Auckland City Hospital-Cancer & Blood Research ( Site 4200)",
                    "status": "RECRUITING",
                    "city": "Auckland",
                    "zip": "1023",
                    "country": "New Zealand",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+6493670000"
                        }
                    ],
                    "geoPoint": {
                        "lat": -36.84853,
                        "lon": 174.76349
                    }
                },
                {
                    "facility": "Hospital Universitario Central de Asturias-Medical Oncology ( Site 1802)",
                    "status": "RECRUITING",
                    "city": "Oviedo",
                    "state": "Asturias",
                    "zip": "33011",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+34646662756"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.36029,
                        "lon": -5.84476
                    }
                },
                {
                    "facility": "Hospital Germans Trias i Pujol-Instituto Catal\u00e1n de Oncolog\u00eda de Badalona ( Site 1806)",
                    "status": "RECRUITING",
                    "city": "Badalona",
                    "state": "Barcelona",
                    "zip": "08916",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "34934978925"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.45004,
                        "lon": 2.24741
                    }
                },
                {
                    "facility": "CHUS - Hospital Clinico Universitario-Servicio de Oncologia ( Site 1807)",
                    "status": "RECRUITING",
                    "city": "Santiago de Compostela",
                    "state": "La Coruna",
                    "zip": "15706",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "981950511"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.88052,
                        "lon": -8.54569
                    }
                },
                {
                    "facility": "HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARA\u00d1ON ( Site 1801)",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "state": "Madrid, Comunidad De",
                    "zip": "28007",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+34914269519"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                },
                {
                    "facility": "Hospital Universitari Vall d'Hebron-Oncology ( Site 1800)",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "zip": "08035",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Study Coordinator",
                            "role": "CONTACT",
                            "phone": "+34934894158"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Merck Clinical Trials Information",
                    "url": "https://www.merckclinicaltrials.com/"
                },
                {
                    "label": "Plain Language Summary",
                    "url": "https://trialstransparency.merckclinicaltrials.com/Study.aspx?id=6482-016&kw=6482-016"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "http://engagezone.msd.com/doc/ProcedureAccessClinicalTrialData.pdf",
            "url": "http://engagezone.msd.com/ds_documentation.php"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000015179",
                    "term": "Colorectal Neoplasms"
                },
                {
                    "id": "D000006528",
                    "term": "Carcinoma, Hepatocellular"
                },
                {
                    "id": "D000004938",
                    "term": "Esophageal Neoplasms"
                },
                {
                    "id": "D000016889",
                    "term": "Endometrial Neoplasms"
                },
                {
                    "id": "D000001661",
                    "term": "Biliary Tract Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                },
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000007414",
                    "term": "Intestinal Neoplasms"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000012002",
                    "term": "Rectal Diseases"
                },
                {
                    "id": "D000008113",
                    "term": "Liver Neoplasms"
                },
                {
                    "id": "D000008107",
                    "term": "Liver Diseases"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000004935",
                    "term": "Esophageal Diseases"
                },
                {
                    "id": "D000014594",
                    "term": "Uterine Neoplasms"
                },
                {
                    "id": "D000005833",
                    "term": "Genital Neoplasms, Female"
                },
                {
                    "id": "D000014565",
                    "term": "Urogenital Neoplasms"
                },
                {
                    "id": "D000014591",
                    "term": "Uterine Diseases"
                },
                {
                    "id": "D000005831",
                    "term": "Genital Diseases, Female"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000091662",
                    "term": "Genital Diseases"
                },
                {
                    "id": "D000001660",
                    "term": "Biliary Tract Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M9613",
                    "name": "Carcinoma, Hepatocellular",
                    "asFound": "Carcinoma, Hepatocellular",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17890",
                    "name": "Colorectal Neoplasms",
                    "asFound": "Colorectal Neoplasms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M19235",
                    "name": "Endometrial Neoplasms",
                    "asFound": "Endometrial Neoplasms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "asFound": "Esophageal Neoplasms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4947",
                    "name": "Biliary Tract Neoplasms",
                    "asFound": "Biliary Tract Neoplasms",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M10448",
                    "name": "Intestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14844",
                    "name": "Rectal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11113",
                    "name": "Liver Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M11107",
                    "name": "Liver Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8085",
                    "name": "Esophageal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17342",
                    "name": "Uterine Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8945",
                    "name": "Genital Neoplasms, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M17315",
                    "name": "Urogenital Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M17339",
                    "name": "Uterine Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8943",
                    "name": "Genital Diseases, Female",
                    "relevance": "LOW"
                },
                {
                    "id": "M2876",
                    "name": "Genital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M4946",
                    "name": "Biliary Tract Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "asFound": "Esophageal Neoplasms",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000582435",
                    "term": "Pembrolizumab"
                },
                {
                    "id": "C000531958",
                    "term": "Lenvatinib"
                },
                {
                    "id": "C000720612",
                    "term": "Belzutifan"
                }
            ],
            "ancestors": [
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000082082",
                    "term": "Immune Checkpoint Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000047428",
                    "term": "Protein Kinase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M349416",
                    "name": "Pembrolizumab",
                    "asFound": "Mg/m2",
                    "relevance": "HIGH"
                },
                {
                    "id": "M353738",
                    "name": "Lenvatinib",
                    "asFound": "Approved",
                    "relevance": "HIGH"
                },
                {
                    "id": "M348353",
                    "name": "Belzutifan",
                    "asFound": "Exclusive breastfeeding",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M2342",
                    "name": "Immune Checkpoint Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M25820",
                    "name": "Protein Kinase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}